Treatment of ursodeoxycholic acid with glucocorticoids and immunosuppressants may improve the long-term survival rate in primary biliary cholangitis patients

Primary biliary cholangitis (PBC) is an autoimmune cholestatic liver disease. The clinical effectiveness of ursodeoxycholic acid (UDCA) plus glucocorticoids and/or immunosuppressants remains controversial in PBC patients. The study aimed to compare the efficacy of monotherapy and combination therapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zi-Long, Jin, Rui, Hao, Mei, Xie, Yan-Di, Liu, Zhi-Cheng, Wang, Xiao-Xiao, Feng, Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
4500
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9678505/
https://www.ncbi.nlm.nih.gov/pubmed/36401422
http://dx.doi.org/10.1097/MD.0000000000031395

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9678505/
https://www.ncbi.nlm.nih.gov/pubmed/36401422
http://dx.doi.org/10.1097/MD.0000000000031395

Ejemplares similares